VM4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vanda Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 15.32 EUR 3.1% Market Closed

Market Cap: €853.5m

V	Vanda Pharmaceuticals Inc XBER:VM4	US
	AC Immune SA NASDAQ:ACIU	CH
R	Rolls-Royce Holdings PLC XBER:RRU	UK
A	Ardelyx Inc F:41X	US
A	ArcelorMittal SA MAD:MTS	LU
	Isuzu Motors Ltd F:ISUA	JP
L	L3harris Technologies Inc XBER:HRS	US
E	Expeditors International of Washington Inc XMUN:EW1	US
T	Tokyo Gas Co Ltd DUS:TOG	JP
N	Navient Corp F:10D	US
M	Macerich Co F:M6G	US

Profitability Summary

Vanda Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

94%

Strong 3Y Average Gross Margin

93%

Gross Margin is Increasing

91% > 94%

Negative Operating Margin

-70%

Negative 3Y Average Operating Margin

-23%

Declining Operating Margin

6% > -70%

Negative Net Margin

-102%

Negative 3Y Average Net Margin

-17%

Declining Net Margin

6% > -102%

Negative Free Cash Flow Margin

-51%

Negative 3Y Average Free Cash Flow Margin

-10%

Declining Free Cash Flow Margin

23% > -51%

Negative ROE

-51%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-21%

Declining ROIC

7% > -104%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.